BC PharmaCare Considering Holkira Pak

Holkira Pak Survey LogoHolkira Pak (generic name: ombitasvir/paritaprevir/ritonavir/dasabuvir) is being considered for BC PharmaCare coverage. The dates for input into this process are Wednesday, April 22nd, to Wednesday, May 20th—now.

If you are a BC resident and answer yes to any of the following questions for Holkira Pak, BC’s Health Care system wants to hear your input:

  1. Do you have hep C?
  2. Are you a caregiver to someone who has hep C?
  3. Does your patient group represent patients who have hep C AND have you registered with PharmaCare to give input? (Learn more about registering your organization).

Links to input questionnaire for Holkira Pak can be found at PharmaCare’s Your Voice.

The Hepatitis C Treatment Information Project includes more information about Holkira Pak and Holkira Pak clinical trial results.

For more information, please contact Your Voice or the Hepatitis C Treatment Information Project.